Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.92−0.06 (-6.62%)
Close on Nov 18, 2026Market cap $11.30MP/E –Yield –
Pluri price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pluri's price to sales ratio was 12.8× on Nov 11, 2026, against 23.2× a year earlier. Over the last 5 years it ranged from 10.7× to 236.1×, with a median of 45.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.8× | −5.6 |
| 2025 | Dec 31, 2025 | 18.4× | −21.0 |
| 2024 | Dec 31, 2024 | 39.4× | −55.2 |
| 2023 | Dec 29, 2023 | 94.6× | −2.7 |
| 2022 | Oct 31, 2022 | 97.2× | +53.5 |
| 2016 | Oct 31, 2016 | 43.7× | −192.4 |
| 2015 | Dec 31, 2015 | 236.1× | −222.9 |
| 2014 | Dec 31, 2014 | 459.0× | +95.1 |
| 2013 | Dec 31, 2013 | 363.9× | +16.8 |
| 2012 | Dec 31, 2012 | 347.1× | – |
See a number that looks wrong?